EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk Factors and Treatment Trends for Onychomycosis: A Case–Control Study of Onychomycosis Patients in the All of Us Research Program

Samantha Jo Albucker, Julianne M Falotico iD, Zi-Ning Choo, Justin T Matushansky, Shari R Lipner iD

Journal of Fungi · 29.06.2023 · 9 (7) · 712

DOI: 10.3390/jof9070712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 29.06.2023. Verfasst von Samantha Jo Albucker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tulane University School of Medicine, New Orleans, LA 70112, USA. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introda significant: Onychomycosis is the most common nail disorder seen in clinical practice, and it may have significant impact on patient quality of life. Understanding risk factors for onychomycosis may help to devise screening and treatment guidelines for populations that are more susceptible to this infection. Using a national database, we aimed to explore associations between onychomycosis and age, sex, and underlying medical conditions, as well as to examine current onychomycosis treatment trends. Materials and Methods: We performed a nested, matched, case–control study of patients in the All of Us database aged ≥ 18 years (6 May 2018–1 January 2022). Onychomycosis cases were identified using International Classification of Diseases (ICD) and Systematized Nomenclature of Medicine (SNOMED) diagnostic codes (ICD-9 110.1, ICD-10 B35.1, SNOMED 414941008). Demographic information (i.e., age, sex, and race), treatments, and co-diagnoses for onychomycosis patients and case–controls were recorded. Wald’s test applied to multivariate logistic regression was used to calculate odds ratios and p-values between onychomycosis and co-diagnoses. Additionally, 95% confidence intervals were calculated with a proportion test.

Results

We included 15,760 onychomycosis patients and 47,280 matched controls. The mean age of onychomycosis patients was 64.9 years, with 54.2% female, 52.8% Non-Hispanic White, 23.0% Black, 17.8% Hispanic, and 6.3% other, which was similar to controls. Patients with onychomycosis vs. controls were more likely to have a co-diagnosis of obesity (46.4%, OR 2.59 [2.49–2.69]), tinea pedis (21.5%, OR 10.9 [10.1–11.6]), peripheral vascular disease (PVD) (14.4%, OR 3.04 [2.86–3.24]), venous insufficiency (13.4%, OR 3.38 [3.15–3.59]), venous varices (5.6%, OR 2.71 [2.47–2.97]), diabetes mellitus (5.6%, OR 3.28 [2.98–3.61]), and human immunodeficiency virus (HIV) (3.5%, OR 1.8 [1.61–2.00]) (p < 0.05, all). The most frequently prescribed oral and topical medications were terbinafine (20.9%) and ciclopirox (12.4%), respectively. The most common therapeutic procedure performed was debridement (19.3%). Over the study period, ciclopirox prescriptions (Spearman correlation 0.182, p = 0.0361) and fluconazole prescriptions increased (Spearman correlation 0.665, p = 2.44 × 10−4), and griseofulvin (Spearman correlation −0.557, p = 0.0131) and itraconazole prescriptions decreased (Spearman correlation −0.681, p = 3.32 × 10−6).

Conclusions

Our study demonstrated that age, obesity, tinea pedis, PVD, venous insufficiency, diabetes mellitus, and HIV were significant risk factors for onychomycosis. In addition, the most frequent oral and topical onychomycosis medications prescribed were terbinafine and ciclopirox, likely reflective of efficacy and cost considerations. Identifying and managing these risk factors is essential to preventing onychomycosis’ primary infections and recurrences and improving treatment efficacy.

Schlagwörter

Stichwörter der Autor:innen

antifungalscomorbiditiesfungusnail diseasenail dystrophynail infectiononychomycosisprocedures

Autor:innen und Institutionen

  • Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Renaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, USA.
  • Weill Cornell Medical College, New York, NY 10021, USA.
  • Columbia University, New York, NY 10027, USA.
  • Department of Dermatology, Weill Cornell Medicine, New York, NY 10021, USA.

ORCID-Profile: Julianne M Falotico, Shari R Lipner

Zitieren

APA

Albucker, S. J., Falotico, J. M., Choo, Z. N., Matushansky, J. T., & Lipner, S. R. (2023). Risk Factors and Treatment Trends for Onychomycosis: A Case–Control Study of Onychomycosis Patients in the All of Us Research Program. Journal of Fungi, 9(7), 712. https://doi.org/10.3390/jof9070712

Vancouver

Albucker SJ, Falotico JM, Choo ZN, Matushansky JT, Lipner SR. Risk Factors and Treatment Trends for Onychomycosis: A Case–Control Study of Onychomycosis Patients in the All of Us Research Program. Journal of Fungi. 2023;9(7):712. doi:10.3390/jof9070712

BibTeX
@article{Albucker2023,
  author = {Albucker, Samantha Jo and Falotico, Julianne M and Choo, Zi-Ning and Matushansky, Justin T and Lipner, Shari R},
  title = {Risk Factors and Treatment Trends for Onychomycosis: A Case–Control Study of Onychomycosis Patients in the All of Us Research Program},
  journal = {Journal of Fungi},
  year = {2023},
  volume = {9},
  number = {7},
  pages = {712},
  doi = {10.3390/jof9070712}
}
Kostenlos starten →